A new review article by an international working group is now available
My colleague Gerry Quinn from the Centre for Molecular Biology at the University of Ulster in Northern Ireland published an important review paper some time ago on the problems and missteps during the COVID-19 pandemic. I helped with it in part [1]. We have now published a new review paper with a similar group of authors on the issues surrounding the mRNA platform. Whilst the paper primarily focuses on the COVID-19 vaccines, as these were the first products to be produced and authorised using this platform, it is important to bear in mind that this is an entirely new pharmaceutical technology, and the industry will pull out all the stops to harness the momentum generated by the COVID-19 vaccines for other vaccines.